• Novartis
• Celldex Therapeutics
• PersonGen BioTherapeutics
• Loxo Oncology
• Kite Pharma
• Bio-Path Holdings
• MEI Pharma/Kyowa Kirin
• MorphoSys
• Beijing Mabworks Biotech
Published | Pages | Publisher | Report code |
---|---|---|---|
Oct 2021 | 60 | DelveInsight | ASDR-592090 |
• Novartis
• Celldex Therapeutics
• PersonGen BioTherapeutics
• Loxo Oncology
• Kite Pharma
• Bio-Path Holdings
• MEI Pharma/Kyowa Kirin
• MorphoSys
• Beijing Mabworks Biotech